Altered patterns of CD44 epitope expression in human chronic and acute myeloid leukemia

Leukemia

Volumn 10, Issue 11, 1996, Pages 1773-1781

  Ghaffari, S ^a,b   Dougherty, G J ^a,b   Eaves, A C ^a,b   Eaves, C J ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Acute myeloid leukemia; CD44; Chronic myeloid leukemia; Fluorescence activated cell sorting; Hyaluronic acid

Indexed keywords

CD34 ANTIGEN; EPITOPE; HERMES ANTIGEN; PHORBOL ESTER;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CANCER CELL; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROLEUKEMIA CELL; EXON; HUMAN; HUMAN CELL; LEUKEMIA CELL; MEGAKARYOBLAST; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0029798476     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Screaton GR, Bell MV, Jackson DC, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89: 12160-12164.
2. Tolg C, Hofmann M, Herrlich P, Ponta H. Splice choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 1993; 21: 1225-1229.
3. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1303-1313.
4. Culty M, Miyake K, Kincade PW, Silorski E, Butcher EC, Underhill C. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol 1990; 111: 2765-2774.
5. Gallagher JT, Spooncer E, Dexter MT. Role of the cellular matrix in haemopoiesis. J Cell Sci 1983; 63: 155-171.
6. Underhill C. CD44: the hyaluronan receptor. J Cell Sci 1992; 103: 293-298.
7. Jalkanen S, Jalkanen M. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 1992; 116: 817-825.
8. Brown TA, Bouchard T, St John T, Wayner E, Carter WG. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol 1991; 113: 207-221.
9. Bennett KL, Jackson DC, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman C, Aruffo A. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 1995; 128: 687-698.
10. Trowbridge IS, Lesley J, Schulte R, Hyman R, Trotter J. Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues. Immunogenetics 1982; 15: 299-312.
11. Kansas GS, Muirhead MJ, Dailey MO. Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans. Blood 1990; 76: 2483-2492.
12. Lewinsohn DM, Nagler A, Ginzton N, Greenberg P, Butcher EC. Hematopoietic progenitor cell expression of the H-CAM (CD44) homing-associated adhesion molecule. Blood 1990; 75: 589-595.
13. Ghaffari S, Dougherty GJ, Lansdorp PM, Eaves AC, Eaves CJ. Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia. Blood 1995; 86: 2976-2985.
14. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol 1993; 54: 271-335.
15. Dougherty GJ, Lansdorp PM, Cooper DL, Humphries RK. Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte 'homing' receptor expressed by hemopoietic cells. J Exp Med 1991; 174: 1-5.
16. Murakami S, Miyake K, Kincade PW, Hodes RJ. Functional role of CD44 (Pgp-1) on activated B cells. Immunol Res 1991; 10: 15-27.
17. Stamenkovic I, Aruffo A, Amiot M, Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 1991; 10: 343-348.
18. Hathcock KS, Hirano H, Murakami S, Hodes RJ. CD44 expression on activated B cells. J Immunol 1993; 151: 6712-6722.
19. Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992; 340: 1053-1058.
20. Horst E, Meijer CJ, Radaskiewicz T, van Dongen JJ, Pieters R, Figdor CG, Hooftman A, Pals ST. Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development. Leukemia 1990; 4: 383-389.
21. Salles G, Zain M, Jiang W, Boussiotis VA, Shipp MA. Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies. Blood 1993; 82: 3539-3547.
22. Koopman G, Heider KH, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993; 177: 897-904.
23. Hofmann M, Rudy W, Zoller M, Tolg C, Ponta H, Herrlich P, Gunthert U. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 1991; 51: 5292-5297.
24. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haubmann I, Matzku S, Wenzel A, Ponta H, Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24.
25. Kortlepel K, Bendall LJ, Gottlieb DJ. Human acute myeloid leukaemic cells express adhesion proteins and bind to bone marrow fibroblast monolayers and extracellular matrix proteins. Leukemia 1993; 7: 1174-1179.
26. Dougherty GJ, Cooper DL, Memory JF, Chiu RK. Ligand binding specificity of alternatively-spliced CD44 isoforms. Recognition of hyaluronan by CD44R1. J Biol Chem 1994; 269: 9074-9078.
27. Dougherty CJ, Dougherty ST, Dirks JF, Chui RK, Peters CE, Droll A. Regulation of the functional activity and ligand binding specificity of the adhesion protein CD44. Trends Glycosci Glycotechnol 1995; 7: 45-56.
28. Koeffler HP, Billing R, Lusis AJ, Sparkes R, Golde DW. An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood 1980; 56: 265-273.
29. Lozzio BB, Lozzio CB, Bamberger EG, Feliu AS. A multipotential leukemia cell line (K-562) of human origin. Proc Soc Exp Biol Med 1981; 166: 546-550.
30. Avanzi GC, Lista P, Giovinazzo B, Miniero R, Saglio G, Benetton G, Coda R, Cattoretti G, Pegoraro L. Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features. Br J Haematol 1988; 69: 359-366.
31. Welte K, Platzer E, Lu L, Gabrilove JL, Levi E, Mertelsmann R, Moore MAS. Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci USA 1985; 82: 1526-1530.
32. Kitamura T, Tojo A, Kuwaki T, Chiba S, Miyazono K, Urabe A, Takaku F. Identification and analysis of human erythropoietin receptors on a factor-dependent cell line, TF-1. Blood 1989; 73: 375-380.
33. Morgan DA, Gumucio DL, Brodsky I. Granulocyte-macrophage colony-stimulating factor-dependent growth and erythropoietin-induced differentiation of a human cell line MB-02. Blood 1991; 78: 2860-2871.
34. Schmitt C, Eaves CJ, Lansdorp PM. Expression of CD34 on human B cell precursors. Clin Exp Immunol 1991; 85: 168-173.
35. Thomas TE, Abraham SJR, Otter AJ, Blackmore EW, Lansdorp PM. High gradient magnetic separation of cells on the basis of expression levels of cell surface antigens. J Immunol Meth 1992; 154: 245-252.
36. de Belder AN, Wik KO. Preparation and properties of fluorescein-labelled hyaluronate. Carbohydr Res 1975; 44: 251-257.
37. Hammarskjold ML, Wang SC, Klein G. High-level expression of the Epstein-Barr virus EBNA1 protein in CV1 cells and human lymphoid cells using a SV40 late replacement vector. Gene 1986; 43: 41-50.
38. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 1982; 257: 7847-7851.
39. Lesley J, Schulte R, Hyman R. Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. Exp Cell Res 1990; 187: 224-233.
40. Lesley J, Howes N, Perschl A, Hyman R. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J Exp Med 1994; 180: 383-387.
41. Bennett KL, Modrell B, Greenfield B, Bartolazzi A, Stamenkovic I, Peach R, Jackson DG, Spring F, Aruffo A. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J Cell Biol 1995; 131: 1623-1633.
42. Cooper DL, Dougherty GJ. To metastasize or not? Selection of CD44 splice sites. Nature Med 1995; 1: 635-637.
43. Katoh S, Zheng Z, Oritani K, Shimozato T, Kincade PW. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med 1995; 182: 419-429.
44. Lesley J, English N, Perschl A, Gregoroff J, Hyman R. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med 1995; 182: 431-437.
45. Maki G, Dougherty G, Takei F, Klingemann H. Activation of protein tyrosine phosphorylation in the human NK cell line NK-92 via ICAM-3 and CD44. Natural Immunity 1995; 14: 83.
46. Camp RL, Kraus TA, Pure E. Variations in the cytoskeletal interaction and post-translational modification of the CD44 homing receptor in macrophages. J Cell Biol 1991; 115: 1283-1292.
47. Kalomiris EL, Bourguignon LYW. Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin. J Cell Biol 1988; 106: 319-327.
48. Kalomiris EL, Bourguignon LYW. Lymphoma protein kinase C is associated with the transmembrane glycoprotein, GP85, and may function in CP-85-ankyrin binding. J Biol Chem 1989; 264: 8113-8119.
49. Lokeshwar VB, Fregien N, Bourguignon LYW. Ankyrin-binding domain of CD44 (GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J Cell Biol 1994; 126: 1099-1109.
50. Morimoto K, Robin E, Le Brousse-Kerdiles MC, Li Y, Clay D. Jasmin C, Smadja-Joffe F. CD44 mediates hyaluronan binding by human myeloid KG1A and KG1 cells. Blood 1994; 83: 657-662.
51. Hofmann M, Rudy W, Gunthert U, Zimmer SG, Zawadzki V, Zoller M, Lichtner RB, Herrlich P, Ponta H. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promotor activity and leads to low-level expression of metastatic-specific variants of CD44 in CREF cells. Cancer Res 1993; 53: 1516-1521.
52. Herrlich P, Rudy W, Hofmann M, Arch R, Zoller M, Zawadzki V, Tolg C, Hekele A, Koopman C, Pals S, Heider K-H, Sleeman J, Ponta H. CD44 and splice variants of CD44 in normal differentiation and tumor progression: In: Hemler ME, Mihich E (eds). Cell Adhesion Molecules. Plenum Press: New York, 1993, pp 265-288.
53. Liesveld JL, Winslow JM, Frediani KE, Ryan DH, Abboud CN. Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells. Blood 1993; 81: 112-121.
54. Levesque JP, Leavesley DI, Niutta S, Vadas M, Simmons PJ. Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med 1995; 181: 1805-1815.